- Home
- SYRE vs BHC Comparison
SYRE vs BHC Comparison
Compare SYRE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | BHC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | BHC |
|---|---|---|
| Price | $33.23 | $7.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $56.50 | $8.50 |
| AVG Volume (30 Days) | 769.3K | ★ 1.8M |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | N/A | ★ $10,029,000,000.00 |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | ★ N/A | $7.75 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $10.91 | $4.25 |
| 52 Week High | $35.31 | $8.69 |
Technical Indicators
Market Signals| Indicator | SYRE | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 56.73 |
| Support Level | $30.00 | $7.23 |
| Resistance Level | $31.69 | $8.00 |
| Average True Range (ATR) | 1.74 | 0.29 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 83.90 | 50.88 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.